Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Razuprotafib

Catalog No. T16724Cas No. 1008510-37-9
Alias AKB-9778

Razuprotafib (AKB-9778) is a protein tyrosine phosphatase ß (HPTPß) inhibitor with an IC50 of 50 nM. It effectively activates Tie-2 and provides protection against acute kidney injury.

Razuprotafib

Razuprotafib

Purity: 95.93%
Catalog No. T16724Alias AKB-9778Cas No. 1008510-37-9
Razuprotafib (AKB-9778) is a protein tyrosine phosphatase ß (HPTPß) inhibitor with an IC50 of 50 nM. It effectively activates Tie-2 and provides protection against acute kidney injury.
Pack SizePriceAvailabilityQuantity
1 mg$253In Stock
5 mg$413In Stock
10 mg$619In Stock
25 mg$1,050In Stock
50 mg$1,370In Stock
100 mg$1,790In Stock
1 mL x 10 mM (in DMSO)$533In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Razuprotafib"

Select Batch
Purity:95.93%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Razuprotafib (AKB-9778) is a protein tyrosine phosphatase ß (HPTPß) inhibitor with an IC50 of 50 nM. It effectively activates Tie-2 and provides protection against acute kidney injury.
Targets&IC50
HPTPß:50 nM
In vitro
Razuprotafib inhibits the phosphatase activity of VE-PTP with an IC50 of 17 pM.
Razuprotafib inhibits the phosphatase PTP1B with an IC50 of 780 nM.
Razuprotafib inhibits HPTPη (IC50 = 36 pM) .
Razuprotafib inhibits HPTPγ (IC50 = 100 pM).
Razuprotafib 0.17 to 50 μM HUVEC 10 minutes in WB
concentration-dependent phosphorylation of TIE2 and downstream components of the TIE2 signaling pathway, including eNOS, AKT, and ERK.
In vivo
Rho-VEGF–transgenic mice s.c. injection 20 mg/kg 12 hours promotes phosphorylation of TIE2 in retinal endothelial cells
Rho-VEGF mice s.c. injection 10-20 mg/kg twice daily for 7 days suppresses subretinal neovascularization.
AliasAKB-9778
Chemical Properties
Molecular Weight586.7
FormulaC26H26N4O6S3
Cas No.1008510-37-9
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 100 mg/mL (170.44 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7044 mL8.5222 mL17.0445 mL85.2224 mL
5 mM0.3409 mL1.7044 mL3.4089 mL17.0445 mL
10 mM0.1704 mL0.8522 mL1.7044 mL8.5222 mL
20 mM0.0852 mL0.4261 mL0.8522 mL4.2611 mL
50 mM0.0341 mL0.1704 mL0.3409 mL1.7044 mL
100 mM0.0170 mL0.0852 mL0.1704 mL0.8522 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Razuprotafib | purchase Razuprotafib | Razuprotafib cost | order Razuprotafib | Razuprotafib chemical structure | Razuprotafib in vivo | Razuprotafib in vitro | Razuprotafib formula | Razuprotafib molecular weight